2 weeks Ago By Defense World Staff
Dimensional Fund Advisors LP boosted its stake in shares of Surgery Partners, Inc. ( NASDAQ:SGRY – Free Report ) by 26.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
The firm owned 2,801,091 shares of the company’s stock after buying an additional 589,499 shares during the period. Dimensional Fund Advisors LP owned about 2.20% of Surgery Partners worth $66,643,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Arizona State Retirement System increased its holdings in shares of Surgery Partners by 1.9% in the 2nd quarter.
Arizona State Retirement System now owns 19,494 shares of the company’s stock valued at $464,000 after purchasing an additional 359 shares during the period. Mesirow Institutional Investment Management Inc. acquired a new position in Surgery Partners during the 2nd quarter worth $12,299,000.
Wolverine Asset Management LLC acquired a new position in shares of Surgery Partners during the second quarter valued at about $552,000. Rhumbline Advisers raised its position in shares of Surgery Partners by 19.6% during the second quarter.
Rhumbline Advisers now owns 127,952 shares of the company’s stock valued at $3,044,000 after buying an additional 20,963 shares during the last quarter. Finally, Natixis Advisors LLC raised its position in shares of Surgery Partners by 11.0% during the second quarter.
Natixis Advisors LLC now owns 12,452 shares of the company’s stock valued at $296,000 after buying an additional 1,237 shares during the last quarter. Surgery Partners Stock Performance Shares of SGRY opened at $31.92 on Friday.
The firm has a 50-day moving average of $30.57 and a 200-day moving average of $27.64.
Surgery Partners, Inc. has a one year low of $22.05 and a one year high of $36.
92. The company has a market cap of $4.06 billion, a PE ratio of 45.
94, a price-to-earnings-growth ratio of 2.50 and a beta of 2.76.
The company has a debt-to-equity ratio of 0.96, a current ratio of 1.83 and a quick ratio of 1.
69. Analysts Set New Price Targets SGRY has been the subject of several recent research reports. Benchmark reissued a “buy” rating and issued a $50.
00 price target on shares of Surgery Partners in a research report on Monday, August 26th. Macquarie initiated coverage on shares of Surgery Partners in a research note on Friday, June 28th. They set an “outperform” rating and a $31.
00 price target on the stock. StockNews.com cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th.
Citigroup cut their target price on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th.
Finally, Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a report on Monday, August 19th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock.
According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $39.86. Get Our Latest Research Report on SGRY Surgery Partners Company Profile ( Free Report ) Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States.
The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. See Also Five stocks we like better than Surgery Partners What Is WallStreetBets and What Stocks Are They Targeting? Can Costco Stock Hit New Highs as Interest Rates Drop? Are Penny Stocks a Good Fit for Your Portfolio? These 3 Stocks Show How to Navigate Declining Consumer Confidence The 3 Best Fintech Stocks to Buy Now MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy? Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter .
.
